![Tapio Juhani Koivu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tapio Juhani Koivu
Directeur Technique/Scientifique/R&D chez University of Helsinki
Postes actifs de Tapio Juhani Koivu
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Helsinki | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Tapio Juhani Koivu
Anciens postes connus de Tapio Juhani Koivu
Sociétés | Poste | Début | Fin |
---|---|---|---|
Teknologian Tutkimuskeskus VTT Oy
![]() Teknologian Tutkimuskeskus VTT Oy Miscellaneous Commercial ServicesCommercial Services Teknologian Tutkimuskeskus VTT Oy provides technology solutions and innovation services. It offers its services in the sectors of bioeconomy, health and wellbeing, digital society, sustainable city, low carbon energy, technology industry, business development, and research infrastructure. The company was founded on January 16, 1942 and is headquartered in Espoo, Finland. | Corporate Officer/Principal | - | - |
Plexpress Oy
![]() Plexpress Oy Pharmaceuticals: GenericHealth Technology Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research. | Directeur/Membre du Conseil | - | - |
Zora Biosciences Oy
![]() Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Directeur/Membre du Conseil | - | - |
Formation de Tapio Juhani Koivu
University of Tampere | Doctorate Degree |
Aalto University | Graduate Degree |
Statistiques
Internationale
Finlande | 7 |
Opérationnelle
Director/Board Member | 2 |
Doctorate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Consumer Services | 4 |
Health Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Zora Biosciences Oy
![]() Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Health Services |
Teknologian Tutkimuskeskus VTT Oy
![]() Teknologian Tutkimuskeskus VTT Oy Miscellaneous Commercial ServicesCommercial Services Teknologian Tutkimuskeskus VTT Oy provides technology solutions and innovation services. It offers its services in the sectors of bioeconomy, health and wellbeing, digital society, sustainable city, low carbon energy, technology industry, business development, and research infrastructure. The company was founded on January 16, 1942 and is headquartered in Espoo, Finland. | Commercial Services |
Plexpress Oy
![]() Plexpress Oy Pharmaceuticals: GenericHealth Technology Plexpress offers high-content gene expression analysis for cell biology research, enabling higher throughput and providing more information than competitors' products. Plexpress analysis service is a cost and time efficient solution for large screens in preclinical drug discovery studies, safety assays and yeast studies. Plexpress was established as a spinoff from the Finnish Technology Research Center VTT in 2007. Including R&D at VTT, the company's TRAC technology has been developed continuously for nearly 10 years and it has been documented in over 15 publications. The technology was originally developed for demanding bioprocess applications, which required a very robust solution for gene expression analysis. The principal developers of the technology, Hans Soderlund and Jari Rautio, are still closely involved with the company as Chairman of the Scientific Advisory Board and VP of R&D, respectively. Since starting operations in 2008, the company has carried out projects using the TRAC technology in the fields of pharmaceutical development and academic research. | Health Technology |
- Bourse
- Insiders
- Tapio Juhani Koivu
- Expérience